Denis Bouchard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Denis Bouchard has a total of 219 co-authors. Here are the top co-authors by number of shared publications:
Michel Pellerin
Department of Surgery, Montreal Heart Institute, Montreal, QC, Canada
19 shared publicationsAmine Mazine
Division of Cardiac Surgery, University of Toronto, Toronto, Ontario, Canada
14 shared publicationsPhilippe Demers
Department of Cardiac Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
14 shared publicationsMichel Carrier
Department of Cardiac Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
9 shared publications- Louis P. Perrault
Montreal Heart Institute Research Centre, Université de Montréal, Montreal, Canada
8 shared publications - Michel Carrier
Division of Cardiac Surgery, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
8 shared publications
Latest Publications
- 4 May 2026
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 172 (2) , 319-331.e4
Contemporary surgical outcomes and repair rates in degenerative mitral regurgitation: Real-world insights from the international MITRACURE registry
- 4 May 2026
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 172 (2) , 319-331.e4
Contemporary surgical outcomes and repair rates in degenerative mitral regurgitation: Real-world insights from the international MITRACURE registry
- Open Access
- 24 March 2026
- Published by Elsevier in JTCVS Techniques
- Vol. 37, 102329
Clip and cure: A minimally invasive strategy for left atrial appendage exclusion and left atrial cryoablation lesion set
- 24 March 2026
- Published by Elsevier in JTCVS Techniques
- Vol. 37, 102329
Open AccessClip and cure: A minimally invasive strategy for left atrial appendage exclusion and left atrial cryoablation lesion set
- Open Access
- 17 March 2026
- Published by Elsevier in JTCVS Techniques
- Vol. 37, 102317
Respect and resect: The art of balance in mitral valve repair
- 17 March 2026
- Published by Elsevier in JTCVS Techniques
- Vol. 37, 102317
Open AccessRespect and resect: The art of balance in mitral valve repair
- 31 August 2025
- Published by Wolters Kluwer Health in Circulation
Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry
Background: Comprehensive knowledge of the clinical presentation, contemporary management, and outcomes on "allcomer" patients referred for mitral valve surgery (MVS) are critical to evaluate current practice and adherence to guidelines, understand selection biases, and inform key stakeholders on quality improvement. Methods: MITRACURE is a large international retrospective registry of consecutive adult patients who underwent isolated or combined MVS for mitral regurgitation (MR) in France or Canada in 2019 with in-depth clinical and echocardiographic characterization. Patients operated on for isolated mitral stenosis or who had a prior mitral valve intervention were excluded. Data were obtained from detailed chart abstraction and were site reported. Results: In 2019, 3522 patients underwent MVS (48% combined) across 40 centers (88±46 MVSs/center, median 80, interquartile [51–131]). Mean age was 65±12 years, and 35% were women. The most common MR etiology was myxomatous (61%), followed by functional (9%), infective endocarditis (9%), and rheumatic disease (7%). MR quantification was performed in only 43%. Advanced clinical presentation was common: 43% were in New York Heart Association class III/IV, 30% exhibited congestive heart failure, 47% were on diuretics, 22% had atrial fibrillation/flutter, 35% presented with reduced ejection fraction, and 22% had pulmonary hypertension (≥50 mm Hg). Most patients were symptomatic or presented with class I/IIa indication for intervention, and an early intervention was performed only in 3% of patients. The repair rate was 62% overall and 80% in myxomatous disease. In-hospital mortality was 4.5% overall but 2.3% in patients with myxomatous MR (1.8% isolated, 3.1% combined). Conclusions: MITRACURE provides a contemporary, multicenter, "real-world" picture of the clinical presentation, management, and in-hospital outcomes of MVS for MR in two Western countries. Patients were often referred late in the disease process, with few patients undergoing early intervention. The higher mortality and lower repair rates reported may be more reflective of an unselected MR patient population but have room for improvement. Our results underline the need to develop strategies to improve management and outcomes of patients with MR.
- 31 August 2025
- Published by Wolters Kluwer Health in Circulation
Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry
Background: Comprehensive knowledge of the clinical presentation, contemporary management, and outcomes on "allcomer" patients referred for mitral valve surgery (MVS) are critical to evaluate current practice and adherence to guidelines, understand selection biases, and inform key stakeholders on quality improvement. Methods: MITRACURE is a large international retrospective registry of consecutive adult patients who underwent isolated or combined MVS for mitral regurgitation (MR) in France or Canada in 2019 with in-depth clinical and echocardiographic characterization. Patients operated on for isolated mitral stenosis or who had a prior mitral valve intervention were excluded. Data were obtained from detailed chart abstraction and were site reported. Results: In 2019, 3522 patients underwent MVS (48% combined) across 40 centers (88±46 MVSs/center, median 80, interquartile [51–131]). Mean age was 65±12 years, and 35% were women. The most common MR etiology was myxomatous (61%), followed by functional (9%), infective endocarditis (9%), and rheumatic disease (7%). MR quantification was performed in only 43%. Advanced clinical presentation was common: 43% were in New York Heart Association class III/IV, 30% exhibited congestive heart failure, 47% were on diuretics, 22% had atrial fibrillation/flutter, 35% presented with reduced ejection fraction, and 22% had pulmonary hypertension (≥50 mm Hg). Most patients were symptomatic or presented with class I/IIa indication for intervention, and an early intervention was performed only in 3% of patients. The repair rate was 62% overall and 80% in myxomatous disease. In-hospital mortality was 4.5% overall but 2.3% in patients with myxomatous MR (1.8% isolated, 3.1% combined). Conclusions: MITRACURE provides a contemporary, multicenter, "real-world" picture of the clinical presentation, management, and in-hospital outcomes of MVS for MR in two Western countries. Patients were often referred late in the disease process, with few patients undergoing early intervention. The higher mortality and lower repair rates reported may be more reflective of an unselected MR patient population but have room for improvement. Our results underline the need to develop strategies to improve management and outcomes of patients with MR.
- 1 December 2021
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 162 (6) , 1714-1725.e2
Contemporary outcomes of aortic and mitral valve surgery for rheumatic heart disease in sub-Saharan Africa
- 1 December 2021
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 162 (6) , 1714-1725.e2
Contemporary outcomes of aortic and mitral valve surgery for rheumatic heart disease in sub-Saharan Africa
- 1 May 2021
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 35 (5) , 1334-1340
Endovascular Vena Cavae Occlusion Technique in Minimally Invasive Tricuspid Valve Surgery in Patients With Previous Cardiac Surgery
- 1 May 2021
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 35 (5) , 1334-1340
Endovascular Vena Cavae Occlusion Technique in Minimally Invasive Tricuspid Valve Surgery in Patients With Previous Cardiac Surgery
- 5 February 2021
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 36 (4) , 1282-1288
Septal myectomy in the era of genetic testing
Background Hypertrophic obstructive cardiomyopathy (HOCM) is one of the most common genetic cardiac diseases and encompasses an array of clinical presentations. Little is known about the impact of genetic background on outcomes after septal myectomy (SM). The aim of this study was to evaluate the effect of specific genetic mutations on midterm outcomes in adults undergoing SM for HOCM. Methods From 2003 to 2020, a total of 59 patients (male = 66%, mean age = 52 ± 13) underwent SM after a preoperative genetic test. Patients were divided into two groups according to their test result (positive or negative). Preoperative echocardiograms were examined to identify phenotypical characteristics of each mutation. Results A total of thirty‐one patients (53%) had a positive genetic test. MYBPC3 was the most common mutation (15/31 patients). Four different phenotypes were identified on preoperative echocardiograms. Overall, Type 1 phenotype was the most common (37% of the cohort). Type 3 was found exclusively in patients with a positive genetic test. Following SM, none of the patients required a redo myectomy or septal ablation. At 10 years, the survival was 97 ± 3% and 100% in patients with a positive and negative genetic test (p = .33), respectively. Conclusion Although our results suggest that the multiple gene mutations present with different characteristics and phenotypes, midterm results of SM appear to be good regardless of genetic mutation presence.
- 5 February 2021
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 36 (4) , 1282-1288
Septal myectomy in the era of genetic testing
Background Hypertrophic obstructive cardiomyopathy (HOCM) is one of the most common genetic cardiac diseases and encompasses an array of clinical presentations. Little is known about the impact of genetic background on outcomes after septal myectomy (SM). The aim of this study was to evaluate the effect of specific genetic mutations on midterm outcomes in adults undergoing SM for HOCM. Methods From 2003 to 2020, a total of 59 patients (male = 66%, mean age = 52 ± 13) underwent SM after a preoperative genetic test. Patients were divided into two groups according to their test result (positive or negative). Preoperative echocardiograms were examined to identify phenotypical characteristics of each mutation. Results A total of thirty‐one patients (53%) had a positive genetic test. MYBPC3 was the most common mutation (15/31 patients). Four different phenotypes were identified on preoperative echocardiograms. Overall, Type 1 phenotype was the most common (37% of the cohort). Type 3 was found exclusively in patients with a positive genetic test. Following SM, none of the patients required a redo myectomy or septal ablation. At 10 years, the survival was 97 ± 3% and 100% in patients with a positive and negative genetic test (p = .33), respectively. Conclusion Although our results suggest that the multiple gene mutations present with different characteristics and phenotypes, midterm results of SM appear to be good regardless of genetic mutation presence.
- 1 January 2020
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 32 (3) , 427-430
Sutureless and Transcatheter Aortic Valve Replacement: When Rivals Become Allies
- 1 January 2020
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 32 (3) , 427-430
Sutureless and Transcatheter Aortic Valve Replacement: When Rivals Become Allies
- 1 November 2019
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 35 (11) , 1475-1482
Mid-term Outcomes in Nonelderly Adults Undergoing Surgery for Isolated Aortic Valve Infective Endocarditis: Results From Two Canadian Centers
- 1 November 2019
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 35 (11) , 1475-1482
Mid-term Outcomes in Nonelderly Adults Undergoing Surgery for Isolated Aortic Valve Infective Endocarditis: Results From Two Canadian Centers
- 1 September 2018
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 106 (3) , 702-707
Relative Adrenal Insufficiency Is Associated With Prolonged Postoperative Hemodynamic Instability
- 1 September 2018
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 106 (3) , 702-707
Relative Adrenal Insufficiency Is Associated With Prolonged Postoperative Hemodynamic Instability